Typical atrial flutter can effectively be treated using single one-minute cryoapplications: Results from a repeat electrophysiological study by Manusama, Randy et al.
Typical atrial flutter can effectively be treated using single
one-minute cryoapplications: Results from a repeat
electrophysiological study
Randy Manusama & Carl Timmermans &
Laurent Pison & Suzanne Philippens & David Perez &
Luz-Maria Rodriguez
Received: 7 October 2008 /Accepted: 1 April 2009 /Published online: 12 June 2009
# The Author(s) 2009. This article is published with open access at Springerlink.com
Abstract
Purpose Catheter-based cryoablation (cryo) has proven to
be as effective as radiofrequency energy (RF) ablation for
the treatment of arrhythmias. Nevertheless, the duration of
cryoapplications has been reported as being significantly
longer than RF applications.
Methods Thirty-seven consecutive patients (28 men; mean
age 59±14 years) with typical atrial flutter (AFL) under-
went cryo of the cavotricuspid isthmus (CTI). Applications
of 1 min were delivered with a 10-French, 10-mm tipped
catheter (CryoCor™). If bidirectional CTI block was not
obtained after 12 1-min applications, applications of 3 min
were selectively delivered to areas of conduction break-
through. The endpoint of the procedure was creation of
bidirectional CTI block and non-inducibility of AFL.
Results A median of 7 (range 3 to 12) 1-min applications
were given along the CTI with a mean temperature of
−88.6±2.3°C. Mean fluoroscopy and procedure time were
27±14 min and 110±28 min respectively. Five patients
required additional 3-min applications; in one patient an
overextended ablation catheter prevented the completion of
the index-procedure. The acute success rate of the index-
procedure was 97%. In 12/24 patients, two with AFL
recurrence, resumption of CTI conduction was found
4 months post-ablation. In all patients bidirectional CTI
block was re-obtained after a median of one 1-min
application. No additional AFL recurrences occurred, after
a mean follow-up of 37±3 (range 30 to 44) months.
Conclusions Cryo of AFL can successfully be performed
using the same application duration as used for RF ablation.
Both acute and long-term results are comparable to RF
ablation. AFL recurrences occurred in only a minority of
patients with resumption of CTI conduction.
Keywords Arrhythmia.Ablation.Catheterablation.
Atrialflutter
1 Introduction
Catheter-based cryoablation (cryo) has proven to be an
effective, safe and versatile tool for arrhythmia treatment.
Despite several advantages, it still requires relatively long
procedure times compared to radiofrequency energy (RF)
catheter ablation. Historically, lesion formation during cryo
is subject to several factors including cooling temperature
[1], application duration, repetition of an application [2]
and convective heating [3, 4], the combination of which can
considerably prolong procedure time. We have shown that a
high efficacy can be maintained when single instead of
repeated freeze thaw cycles are used, which results in a
significant reduction of the procedure time [5]. Other
studies have shown that typical atrial flutter (AFL) can be
effectively treated when the duration of a cryoapplication is
reduced from 5 to 2 min [6–9]. However, it is unknown if
procedural and long-term efficacy remain unaffected if
short cryoapplication times (similar to RF) are used.
Biomedical engineering has enabled deeper cooling temper-
atures and catheter refinements that allow for a reduction of
the application duration. Other factors like contact pressure,
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role in cryo [10, 11]. These developments in cryotechnol-
ogy may have rendered short application times effective.
The purpose of the current study was to prospectively
evaluate the acute and long-term efficacy of cryo for AFL
using single 1-min applications.
2 Patients and methods
2.1 Patients
Thirty-seven consecutive patients (28 men; mean age of 59±
14, range 18 years to 78 years) were included. In 23 patients
the AFL burden could be assessed. This burden of clinical
AFL was documentedfor a medianof8 months, rangingfrom
1 month to 105 months. Ten patients required two or more
cardioversions at the emergency department. In the remaining
14 patients total AFL burden could not be determined.
The study was approved by the hospital ethics commit-
tee and informed consent was obtained from all patients for
both the index-procedure and a repeat electrophysiological
study scheduled 4 months after the index-procedure. The
demographic characteristics of the patients are shown in
Table 1. Twenty-four patients (65%) also had a history of
atrial fibrillation. In four of these patients (17%) atrial
fibrillation organised into AFL during treatment with class
1C anti-arrhythmic drugs (AAD).
2.2 Ablation procedure
The ablation procedure was performed according to a
technique previously defined [7]. AAD were not discon-
tinued before the procedure. All patients were studied in the
fasting state under local anaesthesia. Intravenous heparin
was given as a 100 IU/kg bolus dose directly after insertion
of the venous sheaths, and the activated clotting time was
kept at 300–350 sec by additional heparin bolus throughout
the remainder of the procedure.
Three multipolar catheters were advanced in the right
atrium through insertion of a femoral vein. One 20-pole
electrode catheter (2-mm interelectrode spacing, Halo
catheter, Biosense Webster, Diamond Bar, CA, USA) was
positioned around the tricuspid annulus for sequential
activation mapping. A quadripolar catheter and a decapolar
catheter were placed at the His-bundle and in the coronary
sinus respectively. Cryo was performed using the Cryo-
Cor™ Cardiac Cryoablation System [7]. A steerable 10-
French bipolar catheter with a 10-mm tip was used in
combination with a long venous sheath (St Jude Medical,
SL2; 12F; Daig Co, Minnetonka, MN, USA) for mapping
and ablation of the cavotricuspid isthmus (CTI). After
initial fluoroscopic positioning of the ablation catheter at the
CTI, all subsequent repositioning was done with the aid of
anatomic (fluoroscopic) and electrophysiological guidance.
The 12-lead ECG and intracardiac electrograms were
recorded and stored by the BARD Labsystem Pro. Electro-
grams were analyzed at a gain setting of 0.1 to 0.2 mV/cm
and at a sweep speed of 100–200 mm/s. Entrainment to
confirm isthmus dependency of the AFL circuit was
performed in patients with only AFL and in patients with
AFL and a few episodes of atrial fibrillation. In patients with
AFL and frequent atrial fibrillation episodes, entrainment
was not performed to avoid induction of atrial fibrillation. If
atrial fibrillation was present an attempt was made to regain
sinus rhythm by means of flecainide infusion and/or internal
or external cardioversion. Both catheter-tip temperature and
system pressure were monitored throughout the procedure to
ensure consistent catheter-tip energy delivery. Linear lesions
were created at a target temperature of −90 °C, using single
1-min cryoapplications in a ventriculo-atrial fashion, starting
at the tricuspid annulus edge. If a complete line of block was
not achieved within 12 1-min applications, additional 3-min
applications were used. This cut-off value was used based on
our previous experience with an 8-mm tipped RF catheter
where a mean of 12 applications were necessary to obtain
CTI block [12]. After documentation of bidirectional
isthmus conduction block, incremental atrial pacing from
the proximal coronary sinus was performed without and
with isoproterenol infusion (1–3µg/min) to induce AFL.
Thirty minutes were taken to monitor CTI reconduction
after CTI block was obtained. On the resumption of CTI
Table 1 Demographics
Patients 37
Age, years 59±14
Sex, M/F 28/9
Structural heart disease, n 24
Hypertensive 10
Ischemic 4
Dilated 3
Valvular 1
Hypertensive/ischemic 3
Hypertensive/Dilated 2
Hypertensive/Valvular 1
Mean left ventricular ejection fraction ,% 54±15
Mean left atrial size, mm 45±7
Concomitant atrial fibrillation, n 24
Pacemaker/ICD, n 4/2
IC AFL, n 4
Class III AAD (amiodaron/sotalol/both), n 6/10/1
Other AAD, n 16
n number of patients; AAD anti-arrhythmic drugs; IC AFL organisa-
tion of atrial fibrillation to atrial flutter during; treatment with IC anti-
arrhythmic drugs; ICD intracardiac defibrillator
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complete block was obtained again, whereafter another 30-
min observation was used to confirm CTI block. As stated
above, a maximum of 12 1-min applications (including all
applications prior to isoproterenol infusion) were allowed to
meet procedural endpoints. Thereafter, 3-min applications
were used.
Procedural endpoints were the assessment of bidirec-
tional CTI block and non-inducibility of AFL. Procedure
time was defined as the time interval between the first
femoral vein puncture for catheter insertion and the last
cryoapplication.
2.3 Post-ablation management
A 24-h Holter monitor was given immediately after the
procedure until hospital discharge and thereafter, if symp-
toms suggested an arrhythmia recurrence. Only in patients
with pre-existing atrial fibrillation, AAD were continued
after the ablation procedure. Oral anticoagulation was
started the day of the ablation. After 3 months the necessity
for long-term anticoagulation was reassessed by the number
of AFL/atrial fibrillation recurrences and the presence of
risk factors for thromboembolic complications. Patients
living in the region of Maastricht were followed-up at our
outpatient clinic at 1- and, thereafter, every 3 months. For
patients, from outside this region, follow-up was obtained
by the referring Cardiologist. In case of documentation of
AFL, the patient was again referred to our hospital for
further evaluation and re-ablation. All patients were
instructed to contact our center or the nearest hospital if
they had any symptoms (e.g. palpitations, chest discomfort)
which could indicate a recurrence. Electrophysiological re-
evaluation was performed either after 4 months and/or if
there was a recurrence of AFL. In case of resumption of
isthmus conduction a second ablation was performed using
1-min applications at areas of conduction breakthrough in
an attempt to regain complete bidirectional CTI block. The
electrograms were observed from the ablation catheter-tip
just before the delivery of energy. The amplitude of the
atrial and ventricular component was used for gap local-
isation along the CTI (ventricle, atrioventricular groove,
atrium and atrium-inferior vena cava transition). Conduc-
tion times measured during the electrophysiological re-
evaluation were not compared directly to those obtained
during the index-procedure, since identical electrode posi-
tions could not be guaranteed.
2.4 Statistical analysis
All data are expressed in mean ± SD or median and range.
To compare baseline characteristics between patients with
persistent CTI block and those with CTI reconduction an
unpaired t-test was used for continuous variables and the
chi-square (or Fisher’s exact) test for categorical variables.
When normality and equal variance analyses failed, a
Mann-Whitney rank sum test was used instead of an
unpaired t-test. For differences between patients with
persistent CTI block, CTI reconduction and undetermined
CTI conduction (no repeat electrophysiological study) a
Kruskal-Wallis test was used for continuous variables and
the chi-square test for categorical variables. The signifi-
cance level was set at p<0.05.
3 Results
Details of the electrophysiological study and cryo proce-
dure are summarized in Table 2. All patients had a
documented typical AFL. In one patient an overextended
cryoablation catheter necessitated the use of RF ablation to
complete the procedure. This patient was excluded from
further analysis. In another patient an abnormal atrial
anatomy prevented adequate cannulation of the coronary
sinus prolonging fluoroscopy time. In this patient 11 1-min
applications were delivered to observe isthmus conduction
delay before the procedure was prematurely terminated.
This patient did not show any AFL recurrence during
40 months of follow-up.
The median number of 1-min freezes needed to obtain
the procedural endpoints was 7 (range 3–12). Five patients
(14%) required additional 3-min applications (median 2,
range 2–5). The average temperature during 1-min cryode-
livery was −88.6±2.3 (range −83 to −93) °C and the mean
nadir temperature was −89.0±2.3 (rang −85 to −93) °C.
Isoproterenol infusion was used in all but three patients, in
whom repeated bouts of atrial fibrillation already occurred
during atrial pacing. Nine patients (25%) showed recovery
Table 2 Electrophysiological characteristics of the index-procedure
AFL, CCW/CW 34/3
Cycle length, ms 252±44
Patients requiring cardioversion, 8
Chemical, and 3
Electrical 8
Successful 1-min-application, n 31/36 (86%)
Number of 1-min-applications 7±2
Temperature, °C −88±2
Fluoroscopy time, min 27±14
Procedure time, min 110±28
Acute success, n 35/36 (97%)
Recurrence AFL, n 2/36 (6%)
AFL atrial flutter; CCW counterclockwise; CW clockwise; n number
of patients
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patients bidirectional CTI block could be re-established after
a median of two 1-min applications (range 1–3; eight
patients), and two 3-min applications. No additional appli-
cations were required during a second observation period.
Cardioversion of atrial fibrillation was performed in
eight patients. Sinus rhythm was obtained by internal
cardioversion (n=2), external cardioversion (n=3), or
intravenous administration of flecainide followed by exter-
nal cardioversion (n=3). Mean fluoroscopy and procedure
time were 27±14 (range 8 to 58) and 110±28 (range 61 to
180) minutes respectively.
3.1 Follow-up
After a mean follow-up of 37±3 (range 30 to 44) months, a
recurrence of AFL was registered in only two patients (6%),
2 months and 3 months after the index-procedure respec-
tively. Eleven patients declined a repeated electrophysiolog-
ical study, despite previous informed consent and one patient
died of a non-cardiac cause 2 months after the index-
procedure. A total of 24 patients underwent a repeated
electrophysiological study including both patients with AFL
recurrence. In these two patients, the arrhythmia terminated
after one and two 1-min cryoapplications at the atrioventric-
ular groove. Complete bidirectional CTI block was seen in
12 patients (50%) even though significant fewer cryoappli-
cations were used at the index-procedure compared to those
patients that showed resumption of CTI conduction (P=
0.004; Table 3). Furthermore, no 3-min applications were
required during the index-procedure for those patients who
underwent a repeat electrophysiological study.
In the majority of patients in whom isthmus reconduc-
tion was observed, gaps were found at the atrioventricular
groove (58%). Details concerning their second ablation
procedure are depicted in Table 4. AFL occurred in four
patients: in two patients AFL recurred (as mentioned
above) and in the other two patients AFL was induced
with incremental atrial pacing. Procedural endpoints were
met in all patients after a median of one 1-min application
(range 1–3) without the need of additional applications after
isoproterenol infusion. The patients did not report any
discomfort during cryodelivery [13]. No complications
were seen, including groin hematomas or pseudo-aneurism
formation despite the large diameter of the sheath used.
Of the 24 patients with atrial fibrillation prior to the
procedure, six patients (25 %) underwent additional
pulmonary vein isolation during follow-up because of
recurrent symptomatic episodes.
4 Discussion
4.1 Major findings
The present study demonstrates that a reduction in
application duration as low as 1 min is feasible during cryo
of AFL, resulting in shorter procedure times compared to
previous cryoablation protocols [5–8], while maintaining
similar clinical efficacy. Although a substantial number of
Repeat EPS No Repeat EPS
CTI block CTI conduction Undetermined
Patients 12 12 12
Age, years 56±18 (18–78) 63±10 (51–77) 57±12 (25–71)
Concomitant AF, n 7 10 7
LA size, mm 45±10 (29–63) 43±3 (38–47) 46±9 (30–58)
AFL, CCW/CW 10/2 12/0 11/1
AFL cycle length, ms 261±54 (190–328) 251±59 (180–360) 245±30 (200–300)
Total number of successful 1-min
cryoapplications 6±2 (3–8)*
,** 8±2 (5–12) 8±4 (4–12)
Additional 3-min applications, n 0** 0 5
Reconduction during isoprotenerol, n 6** 2 1
Temperature, ºC −86±2 (−81–−90) −87±3 (−83–−94) −87±1 (−85–−88)
Fluoroscopy time, min 21±12 (8–54)*
,** 26±6 (16–43) 39±20 (11–78)
Procedure time, min 99±22 (67–134) 110±24 (73–145) 119±42 (61–180)
Acute success, n (%) 12 (100) 12 (100) 11 (92)
Recurrence AFL, n (%) 0** 2 (17) 0
Follow-up, months 38±4 (30–41) 38±5 (31–47) 36±4 (30–41)
Table 3 Baseline characteristics
of CTI conduction properties
EPS electrophysiological study;
AF atrial fibrillation; n number
of patients; LA left atrium; AFL
atrial flutter; CCW counter-
clockwise; CW clockwise
*P<0.05 compared to patients
with CTI conduction, **P<0.05
compared to patients with or
undetermined CTI conduction
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after cryo, AFL recurred in only two patients (6%).
4.2 Refinements in cryothermia: Cryo vs. cryo
As opposed to early catheter development using smaller
catheter-tips and higher nadir temperatures [6, 8, 9, 14],
current equipment presented herein enables large lesion
formation reflected by stable CTI conduction block at the
minimum duration of cryodelivery. Applications were
delivered using a 10-F, 10-mm catheter-tip at a mean
temperature of −88.6°C the combination of which allowed
a decrease in the duration of cryodelivery as low as 1 min
per application per site. Lesion formation during cryother-
mia is a complex process involving the synergetic effects of
the initiated expanding cold front during freezing and its
anticipated thawing. As a result shifts in membrane
permeability and osmotic state inflict irreversible cell
damage by massive intracellular swelling ultimately leading
to membrane disruption and loss of cell integrity. Ablation
temperatures beyond −50°C are known to cause irreversible
tissue damage [15] and may enhance passive conduction to
deeper myocardial layers. Deep cooling temperatures may
also delay total thaw duration augmenting the deleterious
effects of affected frozen cells. In addition, contraction of
surrounding (micro) vessels as tissue temperature decreases
may further add to cell decay [15]. Cryo at mean tip-
temperatures of −88.6°C obtained in our study have not
been previously reported and may have an advantage
regarding the abovementioned cumulative effects.
The repetition of a cryoapplication supported by evi-
dence from cryosurgery [2, 16] has long been advocated for
percutaneous applications, since it is known to enhance
tissue injury. This may be because previously damaged cell
structures act as a synctitium to facilitate thermal conduc-
tivity of the following cold front thereby allowing deep
penetration and subsequently more tissue loss [2]. In
conjunction with recent reports [6, 8, 14], our study
supports the reduction in number of applications per site
during transvenous cryodelivery either being the result of
site specific cryoredundancy or differences in biophysics
compared to its extra-luminal counterpart.
Table 4 Electrophysiological and ablation characteristics of patients with CTI conduction recovery
123 4567891 0 1 1 1 2
Index procedure
Pre-ablation AAD amio flec amio BB flec dys sot amio sot flec sot sot
LA size, mm 43 42 41 46 38 41 45 43 42 47 41 42
Concomitant
arrhythmias
AT AF AF/VT AF AF AF AF AF AF CMT/AT AF AF
AFL, CCW/CW CCW CCW CCW CCW CCW CCW CCW CCW CCW CCW CCW CCW
Cycle length, ms 266 240 320 220 300 240 220 220 200 360 220 180
Conduction recovery
during isoprenaline
no yes –
a yes no no no no no no no no
Successful 1-min-
applications
961 24871 1 597 98
Additional applications
1-min/3-min
– 2/0 – 3/0 –––––– ––
Repeat procedure
Recurrence AFL yes no no no yes no no no no no no no
Pre-ablation AAD sot flec amio BB flec dys sot none sot flec sot sot
AFL induction no no yes no no no no no no no yes no
Location terminal
applications/gaps
AV VC AV AV VC AV VC VC AV AV A AV
Conduction recovery
during isoprenaline
no no –
a no no no no no no no no no
Successful 1-min-
applications
321 2111111 22
See text for more details
ano isoprenaline infusion, because of repeated bouts of atrial fibrillation during atrial pacing
AAD anti-arrhythmic drugs; amio amiodarone; flec flecainide; BB beta-blocker; dys dysopyramide; sot sotalol; LA left atrium; AFL atrial flutter;
CMT circus movement tachycardia; AT atrial tachycardia; CCW counter-clock wise; CW clockwise; AV atrioventricular groove; A atrial tissue
between the atrioventricular groove and inferior caval vein, VC atrium-inferior caval vein transition
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study, ablation protocols from previous studies used at least
2 min per application and allowed an increase in application
time up to 5 min to obtain acute and long-lasting success [6,
8, 9, 14]. Furthermore, the number of applications
necessary to maintain CTI block used in these studies was
similar compared to our study indicating equal lesion
formation. Counterintuitively, in our study patients with
stable CTI block required significant fewer applications
compared to patients that showed conduction recovery,
suggesting that other factors like CTI anatomy (eg. pouch-
like configuration) [17] and catheter-tip orientation may
also be important. In an experimental model, Tse et al [18]
favoured the use of long application times, repetition of
applications and horizontal positioning of the catheter-tip in
order to gain maximal tissue injury. Even at maximum
target temperatures of approximately −78°C obtained by
single 2.5-min applications in combination with a 6.5-mm
catheter-tip, lesion geometry could be sufficient to override
CTI dimensions [19] thus prohibiting excess cryodelivery
and its attendant delay in procedure time.
4.3 CTI conduction recovery
In the current study, a large proportion of patients showed
isthmus reconduction, without a recurrence of AFL.
Resumption of CTI conduction is not infrequently seen,
but only a few studies systematically re-evaluated CTI
conduction. While complete CTI block is associated with a
high long-term success, most studies have focussed on AFL
recurrences, withholding possible conduction recovery
incapable of AFL re-initiation. Anselme et al [20] reported
conduction recovery in up to 45% of patients (18/40)
treated with RF 1 month after the index-procedure. The
recurrence of AFL was low, though might have been
obscured at early re-evaluation where wound healing may
still be in progress. Schumacher et al [21] performed a
repeat electrophysiological study in 38/41 patients one year
after RF ablation. The authors used non-inducibility of AFL
regardless of CTI block as the primary endpoint. Only 2/22
patients experienced AFL recurrence after previous confir-
mation of bidirectional CTI block, contrary to the 7/13 and
6/6 patients with either unidirectional block or only ≥10 ms
CTI delay respectively. This high incidence of AFL
recurrence may be due to differences in primary endpoints
and the lack of isoproterenol infusion [22] during the
observation period, which proved effective in 25% of our
patients. Montenero et al [14] reported a CTI recovery rate
of 31%, 3 months after treatment with cryo. While the
authors considered this as a possible reservoir for AFL re-
initiation, no AFL recurrence was reported during 9 months
of follow-up. These data confirm that CTI conduction
recovery does not necessarily imply AFL recurrence and
that CTI block after 3 months likely precludes future
recovery. In our study population, two patients without
recurrent AFL were susceptible to AFL induction, suggest-
ing a higher recurrence rate than we described. One cannot
exclude the possibility that the high CTI reconduction rate
was due to the short cryoapplication time. Moreover, early
re-ablation could in part have prevented future AFL from
re-occurring, thereby masquerading a higher AFL recur-
rence rate. On the other hand, no resumption of AFL was
found during substantial long-term follow-up even though
30% of patients declined re-evaluation. This may indicate
either stable CTI block or sufficient CTI delay to prevent
maintenance of a reentry circuit in the right atrium.
Deprived blood supply and differences in cell-to-cell
(mal) orientation [23] may have altered conduction proper-
ties of the remaining viable cells and subsequently their
critical coupling necessary for the development of AFL.
The abovementioned effects may have also increased the
action potential duration of embedded viable cells thereby
influencing their susceptibility and dose-response to AAD
[24, 25]. In addition, one may hypothesize that some
patients with sufficient CTI delay may have had at least in
part AF secondary to degeneration of AFL, thereby
decreasing the amount of reinitiated AFL [26].
Gaps were mainly found at the level of the tricuspid
valve ridge emphasizing the need for adequate catheter
alignment to the underlying tissue to obtain maximum
lesion size. Although cryoadherence facilitates catheter
stability during freezing initial positioning prior to delivery
remains vital. The pouch-like configuration of the isthmus
may hamper an optimal tip-tissue interface necessary to
obtain sufficient injury of deeper myocardial layers. Possi-
bly longer applications or repeated ones are required in this
region to prevent future recurrences.
4.4 Cryoablation vs. RF ablation
By lowering single freeze duration in conjunction with a
10-mm catheter-tip, the procedure time was comparable to
the procedure time obtained by conventional RF ablation
using 4-mm or 8-mm catheter-tips [12, 13, 27]. Shorter RF
ablation times have been reported when using a maximal
voltage-guided approach. One has to consider that proce-
dure time is not always adequately defined and a 30-min
waiting period is not uniformly included.
In addition, the mean number of applications necessary
to obtain bidirectional CTI block was not different from
that required during conventional RF delivery [21]. Fluo-
roscopy time was also comparable to RF, suggesting a
similar time span for catheter handling [27]. More
importantly, these parameters could be adjusted to RF
standards without compromising acute (97%) and long-
term (94%) efficacy.
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The current study was conducted in a small group of
patients. Only two-thirds of the study population agreed to
undergo re-evaluation, which may have biased the observed
CTI conduction recovery and its relation to AFL recur-
rences. As in most studies reporting on long-term efficacy
of AFL, follow-up was mainly based on symptoms.
Therefore, we cannot exclude a higher recurrence rate due
to asymptomatic episodes of AFL.
5 Conclusions
Cryo of AFL can successfully be performed with 1-min
applications, using a 10-mm catheter-tip, resulting in short
procedure times. Both acute and long-term results are
comparable to RF ablation. A high CTI reconduction rate
was observed at follow-up but was not associated with a
similar degree of AFL recurrences. The clinical relevance
of this finding could not be answered by this study.
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